Responses
Clinical and epidemiological research
Concise report
Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.